Skip to content

Psilocybin: all studies

Page 318 of 440: studies 3,171 to 3,180 of 4,392, newest first. Back to the psilocybin overview

Research

Management of obsessive-compulsive disorder in adults

BMJ February 16, 2026 Jonathan S Abramowitz, Amitai Abramovitch, Dean Mckay et al. 1 citation

Obsessive-compulsive disorder (OCD) is a chronic, often debilitating psychiatric condition characterized by intrusive thoughts and behavioral or mental rituals. Although exposure and response prevention (ERP) remains the first line treatment, many individuals do not experience full remission, highlighting the need for innovation. This review provides a comprehensive and up-to-date synthesis of...

DOI: 10.1136/bmj-2024-083443 (opens in new tab) Psychological intervention Telehealth Neuromodulation Psychological therapy +6

Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies

Pharmaceuticals February 14, 2026 Petra Dolenec, Goran Pelčić, Kristina Pilipović et al.

Glaucoma is increasingly recognized as an ischemic neurodegenerative disorder that extends beyond elevated intraocular pressure (IOP) to involve complex vascular, metabolic, and inflammatory mechanisms. Retinal ganglion cells are particularly vulnerable to ischemia-reperfusion injury, oxidative stress, and chronic neuroinflammation, leading to progressive disconnection from central visual...

UK Practitioner Psychologists' Knowledge and Harm Assessment of Psychedelics: A Cross-Sectional Study

Open Mind February 13, 2026 John Moriarty, Alan Robert Bowman, Alison Pocock preprint

Psychedelics are psychoactive substances that alter one's perception, cognition and emotion, as well as one's sense of time, place and self (Nutt, 2023, p.19). Psychedelic-assisted therapy (PAT) involves the carefully controlled administration of a psychedelic substance "alongside structured psychological support, including preparation, guidance during the psychedelic session, and post-session...

Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.

Research Square February 12, 2026 Jenessa N Johnston, Greg Jones, Shiyong Peng et al. preprint

Rapid-acting antidepressants like ketamine and serotonergic psychedelics show promise for treatment-resistant depression (TRD), but the molecular mechanisms that contribute to their therapeutic effects remain unclear. Induced pluripotent stem cells (iPSCs) offer a platform to model human cortical neurons and investigate drug effects in a human-relevant system. Here, iPSCs from individuals with...

The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy

Frontiers in Psychology February 11, 2026 Bettina Habelt 1 citation

Electroencephalography (EEG) recently celebrated its 100-year anniversary, having revolutionized the study of cognitive function across species. Over the past century, neuroelectric measures such as resting-state EEG, event-related potentials (ERP), and event-related oscillations (ERO) have become indispensable not only for advancing our understanding of brain function but also for identifying...

Psychedelics in functional disorders: A scoping review

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 10, 2026 Chiranth Bhagavan, Olivia Carter, Alexander Bryson et al. 1 citation

Functional disorders, characterised by symptoms unexplained by organic disease, impose a significant burden on individuals and healthcare systems. Existing treatments are limited in efficacy, with no effective pharmacotherapies. There is growing evidence supporting the treatment potential of psychedelics in neuropsychiatric conditions, including several distinct functional disorders. This...

DOI: 10.1016/j.pnpbp.2026.111642 (opens in new tab) Observational study Clinical trial Functional impairment Medline +4

Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature

Deviant Behavior February 9, 2026 Blake Beaton 2 citations

Microdosing is a novel approach to the consumption of classic psychedelic substances, such as LSD (lysergic acid diethylamide) and psilocybin that emerged in recent years. Unlike traditional illicit substance use, which often seeks euphoric experiences, microdosing deliberately avoids such effects in pursuit of self-enhancement. This practice has grown in popularity likely due to the perceived...

DOI: 10.1080/01639625.2026.2624690 (opens in new tab) Qualitative research Qualitative analysis Data collection Engineering ethics +3

Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.

Pharmacopsychiatry February 5, 2026 Tianyi Xu, Sabrina Wong, Gia Han Le et al.

Serotonergic psychedelics, such as lysergic acid diethylamide, and psilocybin, and the entactogen 3,4-methylenedioxymethamphetamine exhibit agonist activity at the 5-hydroxytryptamine 2B receptor, a signalling pathway known to mechanistically mediate drug-induced valvular heart disease. This systematic review evaluates whether chronic or repeated use of psychedelics and...

Metamorphosis in Werewolves, Human-flies and Sundry Creatures

February 4, 2026 Gerald Large

In Ken Russell’s film Altered States (1980), the character Dr. Jessup (played by William Hurt) is a psychopathologist who embarks on a journey of intellectual and spiritual self-discovery. After experimenting with isolation tanks, Jessup travels to Mexico to take part in the religious practices of the Indigenous Hinchi, a ceremony that includes ingesting the hallucinogenic mushroom Amanita...

DOI: 10.4324/9781003639282-4 (opens in new tab) Creatures Metamorphosis Subject documents Cannibalism +1

Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models

Research Square February 2, 2026 Ziv Ben-Zion, Guy Simon, Teddy Lazebnik preprint

Abstract Large language models (LLMs) are increasingly consulted by individuals for support during psychedelic experiences ("trip sitting"), yet no framework exists to evaluate whether these models can accurately simulate or safely respond to altered states of consciousness. We aimed to determine if LLMs can be induced to generate narratives resembling human psychedelic experiences and to...